219331 Sigma-Aldrichβ-Catenin/Tcf Inhibitor II, PKF118-310 - Calbiochem
The β-Catenin/Tcf Inhibitor II, PKF118-310 controls the biological activity of β-Catenin/Tcf. This small molecule/inhibitor is primarily used for Cancer applications.
More>> The β-Catenin/Tcf Inhibitor II, PKF118-310 controls the biological activity of β-Catenin/Tcf. This small molecule/inhibitor is primarily used for Cancer applications. Less<<Synonyms: 1,6-Dimethylpyrimido[5,6-e][1,2,4]triazine-5,7-dione, Wnt Pathway Inhibitor X
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Empirical Formula |
|---|
| C₇H₇N₅O₂ |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 219331-10MG |
|
Glass bottle | 10 mg |
|
— |
| References | |
|---|---|
| References | Wei, W., et al. 2010. Int. J. Cancer 126, 2426. Lepourcelet, M., et al. 2004. Cancer Cell 5, 91. |
| Product Information | |
|---|---|
| Form | Dark yellow solid |
| Hill Formula | C₇H₇N₅O₂ |
| Chemical formula | C₇H₇N₅O₂ |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥95% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 219331-10MG | 04055977202106 |
Documentation
β-Catenin/Tcf Inhibitor II, PKF118-310 - Calbiochem SDS
| Title |
|---|
β-Catenin/Tcf Inhibitor II, PKF118-310 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 219331 |
References
| Reference overview |
|---|
| Wei, W., et al. 2010. Int. J. Cancer 126, 2426. Lepourcelet, M., et al. 2004. Cancer Cell 5, 91. |



